Cardiovascular adverse events in immune checkpoint inhibitor clinical trials: A US Food and Drug Administration pooled analysis.

被引：31

作者：

Amiri-Kordestani, Laleh

Moslehi, Javid

Cheng, Joyce

Tang, Shenghui

Schroeder, Robert

Sridhara, Rajeshwari

Karg, Katherine

Connolly, Joseph

Beaver, Julia A.

Blumenthal, Gideon Michael

Pazdur, Richard

机构：

[1] US FDA, Bethesda, MD 20014 USA

[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[3] US FDA, Silver Spring, MD USA

[4] Palantir Technol Inc, Palo Alto, CA USA

来源：

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.3009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3009

引用

页数：2